In the quest to combat Alzheimer’s disease, researchers are exploring the potential of nasal spray containing monoclonal antibodies to target inflammation, a key factor in the progression of the disease. While traditional approaches focus on clearing amyloid plaques and tau tangles in the brain, this innovative method aims to reduce inflammation associated with these hallmarks. A couple’s involvement in this research highlights the collaborative effort between scientists and individuals affected by Alzheimer’s. Stay tuned for updates on this promising avenue for treating Alzheimer’s.
Read more about this — here
